Esophageal Squamous Cell Carcinoma Clinical Trials in Tianjin, Tianjin Municipality
5 recruitingTianjin, Tianjin Municipality, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
Efficacy and Safety of Neo-CRT Plus Serplulimab, Nimotuzumab in Patients With Locally Advanced Resectable ESCC
Resectable Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital46 enrolled1 locationNCT07457528
Recruiting
Phase 2
Benmelstobart Combined With Radiochemotherapy as Neoadjuvant Treatment Iin ESCC
Esophageal Squamous Cell Carcinoma
Shanghai Zhongshan Hospital100 enrolled5 locationsNCT06637163
Recruiting
Phase 2
AK112 Combined With Chemotherapy as the First-line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients
ESCCAdvanced Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital30 enrolled1 locationNCT06489197
Recruiting
Phase 2
A Phase II Study of CRT Combined With QL1706 in ESCC Patients
Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital39 enrolled1 locationNCT05490719
Recruiting
Phase 3
Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)
Esophageal Squamous Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital342 enrolled1 locationNCT04807673